Cancer modeling and network biology: Accelerating toward personalized medicine

Seminars in Cancer Biology

Volumn 30, Issue , 2015, Pages 1-3

  Masoudi Nejad, Ali ^a   Wang, Edwin ^b,c  

^a UNIVERSITY OF TEHRAN   (Iran)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Cancer modeling; Multiscale model; Network reconstruction; Personalized medicine

Indexed keywords

ARTIFICIAL NEURAL NETWORK; CANCER MODELING; CANCER THERAPY; EDITORIAL; HUMAN; MATHEMATICAL MODEL; NETWORK BIOLOGY; PERSONALIZED MEDICINE; PREDICTION; RATING SCALE; SYSTEMS BIOLOGY; BIOLOGICAL MODEL; PROCEDURES; THEORETICAL MODEL; TRENDS;

HUMANS; INDIVIDUALIZED MEDICINE; MODELS, BIOLOGICAL; MODELS, THEORETICAL; SYSTEMS BIOLOGY;

EID: 84919674249     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2014.06.005     Document Type: Editorial

References (20)

1. Martins M.L., Ferreira S.C., Vilela M.J. Multiscale models for the growth of avascular tumors. Phys Life Rev 2007, 4:128-156.
2. Gibbs J.B. Mechanism-based target identification and drug discovery in cancer research. Science 2000, 287:1969-1973.
3. Chang P.L. Clinical bioinformatics. Chang Gung Med J 2005, 28:201-211.
4. Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 1991, 83:757-766.
5. Gonzalez-Angulo A.M., Hennessy B.T., Mills G.B. Future of personalized medicine in oncology: a systems biology approach. J Clin Oncol 2010, 28:2777-2783.
6. Gonzalez-Perez A., Mustonen V., Reva B., Ritchie G.R., Creixell P., Karchin R., et al. Computational approaches to identify functional genetic variants in cancer genomes. Nat Methods 2013, 10:723-729.
7. Kitano H. Computational systems biology. Nature 2002, 420:206-210.
8. Masoudi-Nejad A., Bidkhori G., Hosseini Ashtiani S., Najafi A., Bozorgmehr J.H., Wang E. Cancer systems biology and modeling: microscopic scale and multiscale approaches. Semin Cancer Biol 2015, 30:60-69.
9. Powathil G.G., Swat M., Chaplain M.A. Systems oncology: towards patient-specific treatment regimes informed by multiscale mathematical modelling. Semin Cancer Biol 2015, 30:13-20.
10. Najafi A., Bidkhori G., Bozorgmehr J.H., Koch I., Masoudi-Nejad A. Genome scale modeling in systems biology: algorithms and resources. Curr Genomics 2014, 15:130-159.
11. Wang Z., Butner J.D., Kerketta R., Cristini V., Deisboeck T.S. Simulating cancer growth with multiscale agent-based modeling. Semin Cancer Biol 2015, 30:70-78.
12. Meacham C.E., Morrison S.J. Tumour heterogeneity and cancer cell plasticity. Nature 2013, 501:328-337.
13. Csermely P., Hodsagi J., Korcsmaros T., Modos D., Perez-Lopez A.R., Szalay K., et al. Cancer stem cells display extremely large evolvability: alternating plastic and rigid networks as a potential mechanism: network models, novel therapeutic target strategies, and the contributions of hypoxia, inflammation and cellular senescence. Semin Cancer Biol 2015, 30:42-51.
14. Gerlee P., Kim E., Anderson A.R. Bridging scales in cancer progression: mapping genotype to phenotype using neural networks. Semin Cancer Biol 2015, 30:30-41.
15. Bolouri H. Network dynamics in the tumor microenvironment. Semin Cancer Biol 2015, 30:52-59.
16. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
17. Hsu P.P., Sabatini D.M. Cancer cell metabolism: Warburg and beyond. Cell 2008, 134:703-707.
18. Masoudi-Nejad A., Asgari Y. Metabolic cancer biology: structural-based analysis of cancer as a metabolic disease, new sights and opportunities for disease treatment. Semin Cancer Biol 2015, 30:21-29.
19. Resendis-Antonio O., Gonzalez-Torres C., Jaime-Munoz G., Hernandez-Patino C.E., Salgado-Munoz C.F. Modeling metabolism: a window toward a comprehensive interpretation of networks in cancer. Semin Cancer Biol 2015, 30:79-87.
20. Wang E., Zaman N., McGee S., Milanese J.S., Masoudi-Nejad A., O'Connor-McCourt M. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. Semin Cancer Biol 2015, 30:4-12.